{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m didanosine
to a specific field?
Status:
Investigational
Source:
NCT02295514: Not Applicable Interventional Completed Sepsis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00707642: Phase 1 Interventional Completed West Nile Virus Disease
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:miromavimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:MAVEROPEPIMUT-S COMPONENT SURA2.M [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lusacomfar alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efdoralprin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04631016: Phase 2 Interventional Completed Chronic Obstructive Pulmonary Disease (COPD)
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03976401: Phase 2 Interventional Completed NASH - Nonalcoholic Steatohepatitis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:efbalropendekin alfa [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN
